Lóránd Kis

2.2k total citations
36 papers, 1.2k citations indexed

About

Lóránd Kis is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Lóránd Kis has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Lóránd Kis's work include Viral-associated cancers and disorders (16 papers), Lymphoma Diagnosis and Treatment (11 papers) and Immune Cell Function and Interaction (9 papers). Lóránd Kis is often cited by papers focused on Viral-associated cancers and disorders (16 papers), Lymphoma Diagnosis and Treatment (11 papers) and Immune Cell Function and Interaction (9 papers). Lóránd Kis collaborates with scholars based in Sweden, Japan and Hungary. Lóránd Kis's co-authors include George Klein, Noémi Nagy, Eva Klein, E. Klein, Jan-Ακε Gustafsson, Margaret Warner, Miki Takahara, Johan Hartman, Dániel Salamon and Jonas Bergh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Lóránd Kis

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lóránd Kis Sweden 19 648 370 362 254 167 36 1.2k
Simona Rolla Italy 21 339 0.5× 471 1.3× 223 0.6× 323 1.3× 108 0.6× 43 1.0k
S Dirnhofer Switzerland 25 738 1.1× 499 1.3× 564 1.6× 503 2.0× 129 0.8× 64 1.8k
Peter Nørgaard Denmark 23 785 1.2× 195 0.5× 388 1.1× 707 2.8× 152 0.9× 78 1.6k
Thierry Lavabre‐Bertrand France 19 377 0.6× 309 0.8× 293 0.8× 597 2.4× 83 0.5× 59 1.4k
Chung-Che Chang United States 18 529 0.8× 236 0.6× 255 0.7× 231 0.9× 83 0.5× 49 1.0k
Alessandra Stacchini Italy 26 558 0.9× 638 1.7× 499 1.4× 508 2.0× 90 0.5× 76 1.9k
Irena Frydecka Poland 24 488 0.8× 939 2.5× 247 0.7× 210 0.8× 274 1.6× 103 1.5k
Endi Wang United States 24 546 0.8× 218 0.6× 801 2.2× 557 2.2× 100 0.6× 127 2.0k
Jason A. Dubovsky United States 20 316 0.5× 577 1.6× 418 1.2× 493 1.9× 114 0.7× 45 1.6k
Jean‐Gabriel Judde France 19 946 1.5× 223 0.6× 218 0.6× 581 2.3× 115 0.7× 42 1.5k

Countries citing papers authored by Lóránd Kis

Since Specialization
Citations

This map shows the geographic impact of Lóránd Kis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lóránd Kis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lóránd Kis more than expected).

Fields of papers citing papers by Lóránd Kis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lóránd Kis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lóránd Kis. The network helps show where Lóránd Kis may publish in the future.

Co-authorship network of co-authors of Lóránd Kis

This figure shows the co-authorship network connecting the top 25 collaborators of Lóránd Kis. A scholar is included among the top collaborators of Lóránd Kis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lóránd Kis. Lóránd Kis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Yi Chun, Kenbugul Jatta, Lóránd Kis, et al.. (2019). miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC. Biochemical and Biophysical Research Communications. 511(2). 260–265. 24 indexed citations
2.
Lindh, Claes, Lóránd Kis, Brett Delahunt, et al.. (2019). PD‐L1 expression and deficient mismatch repair in ductal adenocarcinoma of the prostate. Apmis. 127(8). 554–560. 7 indexed citations
3.
Ortiz‐Villalón, Cristian, Nolwenn Le Stang, Françoise Galateau-Sallé, et al.. (2019). Pericardial Mesothelioma:A Multi-institutional Study of 61 cases. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations
4.
Rubio-Terrés, Carlos, Giacomo Puppa, Giovanni De Petris, Lóránd Kis, & Peter T. Schmidt. (2017). The third pathway of colorectal carcinogenesis. Journal of Clinical Pathology. 71(1). 7–11. 12 indexed citations
5.
6.
Rubio-Terrés, Carlos, et al.. (2017). Systematic Classification of Colonic Crypts with Architectural Distortions Inulcerative Colitis. 3(2). 1 indexed citations
7.
Stålhammar, Gustav, Michael Lippert, Nicholas P. Tobin, et al.. (2016). Digital image analysis outperforms manual biomarker assessment in breast cancer. Modern Pathology. 29(4). 318–329. 130 indexed citations
8.
Ma, Ran, John Lövrot, Lóránd Kis, et al.. (2015). mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells. Cancer Letters. 367(1). 76–87. 46 indexed citations
9.
Ma, Limin, Angela Strambi, Pádraig D’Arcy, et al.. (2014). SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth. Cell Death and Disease. 5(10). e1483–e1483. 31 indexed citations
10.
Rubio-Terrés, Carlos, et al.. (2013). Lymphoid aggregates in Crohn's colitis and mucosal immunity. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(5). 637–642. 13 indexed citations
11.
12.
Klein, E., Lóránd Kis, & George Klein. (2007). Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions. Oncogene. 26(9). 1297–1305. 117 indexed citations
13.
Márkász, László, Lóránd Kis, György Stuber, et al.. (2007). Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel. Leukemia & lymphoma. 48(9). 1835–1845. 10 indexed citations
14.
Takahara, Miki, Lóránd Kis, Noémi Nagy, et al.. (2006). Concomitant increase of LMP1 and CD25 (IL‐2‐receptor α) expression induced by IL‐10 in the EBV‐positive NK lines SNK6 and KAI3. International Journal of Cancer. 119(12). 2775–2783. 45 indexed citations
15.
Kis, Lóránd, Miki Takahara, Noémi Nagy, George Klein, & Eva Klein. (2005). Cytokine mediated induction of the major Epstein–Barr virus (EBV)-encoded transforming protein, LMP-1. Immunology Letters. 104(1-2). 83–88. 33 indexed citations
16.
Kim, Hyun‐Jin, Yoko Omoto, Hirotaka Iwase, et al.. (2005). Differential expression of oestrogen receptors in human secondary lymphoid tissues. The Journal of Pathology. 208(3). 408–414. 62 indexed citations
17.
Nishikawa, Jun, Lóránd Kis, Anquan Liu, et al.. (2004). Upregulation of LMP1 Expression by Histone Deacetylase Inhibitors in an EBV Carrying NPC Cell Line. Virus Genes. 28(1). 121–128. 10 indexed citations
18.
Nagy, Noémi, Miki Takahara, Jun Nishikawa, et al.. (2004). Wild-type p53 activates SAP expression in lymphoid cells. Oncogene. 23(53). 8563–8570. 18 indexed citations
19.
Kis, Lóránd, Noémi Nagy, George Klein, & Eva Klein. (2003). Expression of SH2D1A in five classical Hodgkin's disease‐derived cell lines. International Journal of Cancer. 104(5). 658–661. 20 indexed citations
20.
Nagy, Noémi, Akihiko Maeda, Kentaro Bandobashi, et al.. (2002). SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. International Journal of Cancer. 100(4). 433–440. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Rolla Breakdown of academic impact, for papers by S Dirnhofer Breakdown of academic impact, for papers by Peter Nørgaard Breakdown of academic impact, for papers by Thierry Lavabre‐Bertrand Breakdown of academic impact, for papers by Chung-Che Chang Breakdown of academic impact, for papers by Alessandra Stacchini Breakdown of academic impact, for papers by Irena Frydecka Breakdown of academic impact, for papers by Endi Wang Breakdown of academic impact, for papers by Jason A. Dubovsky Breakdown of academic impact, for papers by Jean‐Gabriel Judde
Rankless by CCL
2026